Karline da Costa Rodrigues

Karline da Costa Rodrigues

Auto-generated profile, based on publicly available information

Karline da Costa Rodrigues

Federal University of Pelotas

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2024 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
KRKarline da Costa Rodrigues
Karline da Costa Rodrigues
MNManoel Rodrigues da Silva Neto
Manoel Rodrigues da Silva Neto
VBVictor Barboza
Victor Barboza
Sandra HaasSandra Haas
Sandra Haas
RVRodrigo de Almeida Vaucher
Rodrigo de Almeida Vaucher
CLCristiane Luchese
Cristiane Luchese

16 February 2026 in Redox Report
Verified
Journal Article
Open access
RORenata L. De Oliveira
Renata L. De Oliveira
MPMikaela P. Pinz
Mikaela P. Pinz
GVGuilherme T. Voss
Guilherme T. Voss
KRKarline Da C. Rodrigues
Karline Da C. Rodrigues
AVAne G. Vogt
Ane G. Vogt
CLCristiane Luchese
Cristiane Luchese
Alzheimer's disease (AD) is characterized by cognitive impairment and neuropsychiatric disturbances, including depression, both tightly linked to redox imbalance and neuroinflammatory activation. This study investigated whether the selenium-containing compound 7-chloro-4-(phenylselanyl)quinoline (4-PSQ) mitigates behavioral and biochemical alterations in a β-amyloid (Aβ)-induced mouse model of AD through modulation of redox-regulated pathways. Male Swiss mice received intracerebroventricular Aβ (25-35) or saline (3 µL/site) and were treated orally for seven days with 4-PSQ (1 mg/kg), paroxetine (1 mg/kg), or donepezil (1 mg/kg). Depressive-like behavior and memory performance were assessed, followed by determination of plasma corticosterone, reactive species levels, lipid peroxidation, antioxidant enzyme activities, neuroinflammatory mediators, and acetylcholinesterase (AChE) activity in the hippocampus and prefrontal cortex of mice. 4-PSQ significantly reversed Aβ-induced depressive behavior and memory impairment. The compound normalized plasma corticosterone levels, reduced reactive species and lipid peroxidation, and restored antioxidant enzyme activity. It also decreased the expression of inflammatory markers while regulating AChE activity, indicating concomitant modulation of redox, neuroimmune, and cholinergic pathways. By restoring redox homeostasis and attenuating neuroinflammatory responses, 4-PSQ effectively counteracted behavioral and biochemical disruptions associated with Aβ toxicity. These findings support 4-PSQ as a promising selenium-based therapeutic candidate targeting redox-driven features of AD, including comorbid depression and cognitive decline.

24 November 2025 in Psychopharmacology
Verified
Journal Article
Closed access
PDF file
KRKarline da Costa Rodrigues
Karline da Costa Rodrigues
MOMeliza da Conceição Oliveira
Meliza da Conceição Oliveira
ISIsadora Cielo de Souza
Isadora Cielo de Souza
AIAndreza Wachholz Igansi
Andreza Wachholz Igansi
ALAna Vitória Barbosa Lopes
Ana Vitória Barbosa Lopes
CLCristiane Luchese
Cristiane Luchese